A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

NCT05658146 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb